Concepts (100)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pyruvic Acid | 3 | 2022 | 38 | 1.610 |
Why?
|
| Triple Negative Breast Neoplasms | 6 | 2025 | 273 | 0.900 |
Why?
|
| Spin Labels | 1 | 2024 | 21 | 0.860 |
Why?
|
| Peroxidase | 1 | 2023 | 64 | 0.800 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2025 | 3854 | 0.770 |
Why?
|
| Echo-Planar Imaging | 1 | 2020 | 23 | 0.680 |
Why?
|
| Oxygen | 1 | 2024 | 571 | 0.660 |
Why?
|
| Gout | 1 | 2023 | 167 | 0.640 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2020 | 297 | 0.620 |
Why?
|
| Neoadjuvant Therapy | 4 | 2025 | 402 | 0.600 |
Why?
|
| Prostatic Neoplasms | 3 | 2022 | 1578 | 0.530 |
Why?
|
| Bone Neoplasms | 4 | 2025 | 445 | 0.460 |
Why?
|
| Tumor Microenvironment | 6 | 2025 | 688 | 0.410 |
Why?
|
| Phantoms, Imaging | 3 | 2022 | 147 | 0.380 |
Why?
|
| Neutrophils | 2 | 2025 | 360 | 0.240 |
Why?
|
| Arachidonic Acid | 1 | 2025 | 67 | 0.230 |
Why?
|
| Breast Neoplasms | 3 | 2023 | 2683 | 0.230 |
Why?
|
| Osteogenesis | 2 | 2023 | 163 | 0.220 |
Why?
|
| Carbon Tetrachloride | 1 | 2024 | 6 | 0.220 |
Why?
|
| Myeloid Cells | 1 | 2024 | 118 | 0.210 |
Why?
|
| Immune Tolerance | 1 | 2024 | 153 | 0.210 |
Why?
|
| Lactates | 1 | 2022 | 86 | 0.190 |
Why?
|
| Ecosystem | 1 | 2023 | 107 | 0.190 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2024 | 253 | 0.180 |
Why?
|
| Single-Cell Analysis | 1 | 2025 | 353 | 0.180 |
Why?
|
| B-Lymphocytes | 1 | 2024 | 543 | 0.180 |
Why?
|
| Carbon Isotopes | 1 | 2020 | 233 | 0.160 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2025 | 816 | 0.160 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2020 | 76 | 0.160 |
Why?
|
| Artifacts | 1 | 2020 | 116 | 0.160 |
Why?
|
| Adaptation, Physiological | 1 | 2021 | 274 | 0.150 |
Why?
|
| Neoplasms | 2 | 2025 | 2953 | 0.150 |
Why?
|
| Bone and Bones | 1 | 2021 | 301 | 0.150 |
Why?
|
| Animals | 7 | 2025 | 34953 | 0.150 |
Why?
|
| Neoplasm Metastasis | 1 | 2021 | 725 | 0.140 |
Why?
|
| Receptors, Estrogen | 1 | 2021 | 741 | 0.140 |
Why?
|
| Rats | 1 | 2024 | 3612 | 0.140 |
Why?
|
| Mice | 6 | 2025 | 18566 | 0.130 |
Why?
|
| Kidney | 1 | 2024 | 1333 | 0.130 |
Why?
|
| Liver Cirrhosis | 1 | 2024 | 899 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2023 | 2171 | 0.110 |
Why?
|
| Myelopoiesis | 2 | 2024 | 12 | 0.110 |
Why?
|
| Algorithms | 1 | 2020 | 1724 | 0.100 |
Why?
|
| ROC Curve | 2 | 2024 | 598 | 0.090 |
Why?
|
| Cell Communication | 2 | 2024 | 187 | 0.090 |
Why?
|
| Humans | 13 | 2025 | 132105 | 0.090 |
Why?
|
| Retrospective Studies | 3 | 2025 | 17374 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2020 | 1541 | 0.080 |
Why?
|
| Female | 8 | 2025 | 70680 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2024 | 3021 | 0.060 |
Why?
|
| Osteoclasts | 1 | 2025 | 72 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2025 | 13017 | 0.050 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2025 | 133 | 0.050 |
Why?
|
| Middle Aged | 4 | 2025 | 28936 | 0.050 |
Why?
|
| Anisotropy | 1 | 2024 | 126 | 0.050 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2025 | 399 | 0.050 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2023 | 11 | 0.050 |
Why?
|
| High-Temperature Requirement A Serine Peptidase 1 | 1 | 2023 | 5 | 0.050 |
Why?
|
| Bone Remodeling | 1 | 2023 | 56 | 0.050 |
Why?
|
| Breast | 1 | 2024 | 216 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2024 | 6530 | 0.050 |
Why?
|
| Cadherins | 1 | 2023 | 180 | 0.050 |
Why?
|
| Male | 3 | 2022 | 64918 | 0.050 |
Why?
|
| Aged | 3 | 2025 | 21413 | 0.050 |
Why?
|
| Neoplasm Micrometastasis | 1 | 2021 | 13 | 0.040 |
Why?
|
| Gap Junctions | 1 | 2021 | 45 | 0.040 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2021 | 67 | 0.040 |
Why?
|
| Clonal Evolution | 1 | 2021 | 50 | 0.040 |
Why?
|
| Macrophages | 1 | 2025 | 693 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2021 | 217 | 0.040 |
Why?
|
| Monitoring, Immunologic | 1 | 2020 | 14 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2021 | 316 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2021 | 365 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2025 | 1158 | 0.040 |
Why?
|
| Cell Count | 1 | 2020 | 234 | 0.040 |
Why?
|
| Lactic Acid | 1 | 2020 | 154 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2021 | 396 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2021 | 604 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2020 | 319 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2021 | 757 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 1047 | 0.040 |
Why?
|
| Adult | 3 | 2025 | 31557 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2021 | 679 | 0.040 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2023 | 554 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 998 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2020 | 351 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2025 | 3698 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2020 | 699 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 1305 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2024 | 1758 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2023 | 1975 | 0.030 |
Why?
|
| Disease Progression | 1 | 2021 | 2227 | 0.030 |
Why?
|
| Apoptosis | 1 | 2021 | 1904 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 1879 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2021 | 2512 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 2064 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2021 | 1683 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 4764 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 4694 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2021 | 4725 | 0.020 |
Why?
|